Propionibacterium acnes: an indigenous bacterium may be pathogenic in several cutaneous disease states

Comment

C G Burkhart et al. Arch Dermatol. 2001 Sep.

. 2001 Sep;137(9):1250.

No abstract available

Comment on

The use of tetracyclines for the treatment of sarcoidosis.
Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L. Bachelez H, et al. Arch Dermatol. 2001 Jan;137(1):69-73. doi: 10.1001/archderm.137.1.69. Arch Dermatol. 2001. PMID: 11176663 Clinical Trial.

Propionibacterium acnes.
Perry AL, Lambert PA. Perry AL, et al. Lett Appl Microbiol. 2006 Mar;42(3):185-8. doi: 10.1111/j.1472-765X.2006.01866.x. Lett Appl Microbiol. 2006. PMID: 16478502 Review.
The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
Dessinioti C, Katsambas AD. Dessinioti C, et al. Clin Dermatol. 2010 Jan-Feb;28(1):2-7. doi: 10.1016/j.clindermatol.2009.03.012. Clin Dermatol. 2010. PMID: 20082942 Review.
Insights in the pathogenic potential of Propionibacterium acnes from its complete genome.
Brüggemann H. Brüggemann H. Semin Cutan Med Surg. 2005 Jun;24(2):67-72. doi: 10.1016/j.sder.2005.03.001. Semin Cutan Med Surg. 2005. PMID: 16092793 Review.
Acne and Propionibacterium acnes.
Bojar RA, Holland KT. Bojar RA, et al. Clin Dermatol. 2004 Sep-Oct;22(5):375-9. doi: 10.1016/j.clindermatol.2004.03.005. Clin Dermatol. 2004. PMID: 15556721 Review.
Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis.
Ishige I, Eishi Y, Takemura T, Kobayashi I, Nakata K, Tanaka I, Nagaoka S, Iwai K, Watanabe K, Takizawa T, Koike M. Ishige I, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Mar;22(1):33-42. Sarcoidosis Vasc Diffuse Lung Dis. 2005. PMID: 15881278